As of 2026-04-03, the Relative Valuation of Abbott Laboratories (ABT) is 118.90 USD. This relative valuation is based on P/E multiples. With the latest stock price at 102.87 USD, the upside of Abbott Laboratories based on Relative Valuation is 15.6%.
The range of the Relative Valuation is 105.58 - 136.80 USD.
| Range | Selected | |
| Trailing P/E multiples | 28.1x - 34.3x | 30.4x |
| Forward P/E multiples | 22.9x - 28.8x | 26.0x |
| Fair Price | 105.58 - 136.80 | 118.90 |
| Upside | 2.6% - 33.0% | 15.6% |
| Date | P/E |
| 2026-04-02 | 27.40 |
| 2026-04-01 | 27.27 |
| 2026-03-31 | 27.35 |
| 2026-03-30 | 27.14 |
| 2026-03-27 | 27.70 |
| 2026-03-26 | 27.85 |
| 2026-03-25 | 27.92 |
| 2026-03-24 | 27.72 |
| 2026-03-23 | 27.93 |
| 2026-03-20 | 28.09 |
| 2026-03-19 | 28.55 |
| 2026-03-18 | 28.90 |
| 2026-03-17 | 29.49 |
| 2026-03-16 | 29.29 |
| 2026-03-13 | 28.77 |
| 2026-03-12 | 28.80 |
| 2026-03-11 | 29.37 |
| 2026-03-10 | 29.45 |
| 2026-03-09 | 30.00 |
| 2026-03-06 | 29.18 |
| 2026-03-05 | 29.58 |
| 2026-03-04 | 30.12 |
| 2026-03-03 | 30.26 |
| 2026-03-02 | 30.40 |
| 2026-02-27 | 30.99 |
| 2026-02-26 | 30.97 |
| 2026-02-25 | 30.57 |
| 2026-02-24 | 30.52 |
| 2026-02-23 | 30.71 |
| 2026-02-20 | 29.89 |
| 2026-02-19 | 29.88 |
| 2026-02-18 | 30.17 |
| 2026-02-17 | 29.90 |
| 2026-02-13 | 30.01 |
| 2026-02-12 | 29.69 |
| 2026-02-11 | 30.25 |
| 2026-02-10 | 29.91 |
| 2026-02-09 | 29.58 |
| 2026-02-06 | 29.52 |
| 2026-02-05 | 29.05 |
| 2026-02-04 | 28.82 |
| 2026-02-03 | 29.04 |
| 2026-02-02 | 29.14 |
| 2026-01-30 | 29.11 |
| 2026-01-29 | 28.26 |
| 2026-01-28 | 28.25 |
| 2026-01-27 | 28.84 |
| 2026-01-26 | 28.97 |
| 2026-01-23 | 28.61 |
| 2026-01-22 | 28.93 |